German Healthcare Services Stock News

If you are wondering whether flatexDEGIRO's share price still offers value at current levels, the key question is how its market price compares with its underlying fundamentals. The stock recently closed at €30.48, with returns of 0.2% over 7 days, 1.4% over 30 days, a 16.0% decline year to date, and 29.2% over the last year. Together, these figures give mixed signals about how the market is pricing its prospects and risks. Recent coverage has focused on flatexDEGIRO's position within online...

Fresenius Medical Care (XTRA:FME) has amended its distribution agreement with Humacyte, Inc. regarding Symvess, an investigational acellular tissue engineered vessel. The revision realigns ex U.S. rights to Symvess and reshapes how the two companies coordinate on access to this advanced vascular product outside the United States. For you as an investor, this move sits at the intersection of medical technology and chronic kidney care, where XTRA:FME is a major global provider. Access to next...

While Clearway Energy, Inc. ( FRA:NY4B ) might not have the largest market cap around , it saw a significant share...

Wacker Chemie (XTRA:WCH) has caught investor attention after reporting Q1 EBITDA of €173 million, a 45% year-over-year increase, supported by its PACE cost program and upgraded full-year 2026 sales expectations. See our latest analysis for Wacker Chemie. Wacker Chemie’s share price has moved to €93.65, with a 30-day share price return of 14.14% and a 90-day return of 35.53%. The 1-year total shareholder return of 44.43% contrasts with weaker 3 and 5-year total returns, suggesting momentum has...

adidas AG ( ETR:ADS ) is about to trade ex-dividend in the next four days. The ex-dividend date is commonly two...

Wondering if Rheinmetall at €1,355.80 is pricing in too much optimism or leaving room on the table for value focused investors like you? The stock is up 2.8% over the last week, but shows a 13.7% decline over 30 days, a 15.4% decline year to date, and a 13.5% decline over the past year, all following a very large 3 year gain and an even larger 5 year gain. Recent coverage has focused on Rheinmetall's position in defense and capital goods, which often draws attention whenever sector sentiment...

BASF (XTRA:BAS) has just opened 2026 with Q1 numbers that cap a year where trailing twelve month revenue sat at about €59.7b and basic EPS came in at €1.61. Over recent quarters, the company has seen revenue move from €17.6b and EPS of €1.53 in Q1 2024 to €14.0b and EPS of €0.57 in Q4 2025, with trailing net income from continuing operations at €1.43b across the last reported twelve months. With net profit margins over the past year at 2.4% and earnings growth of 26.6% supported by forecasts...

Investors may be wondering whether Deutsche Telekom's share price reflects its true worth, or if the market is mispricing this telecom heavyweight right now. The stock last closed at €27.57, with a 10.4% decline over 30 days and a 10.3% decline over 1 year, despite longer term returns of 41.7% over 3 years and 96.4% over 5 years, which hint at a very different picture. Recent headlines have focused on Deutsche Telekom's position within the European telecom sector, including its role in...

It looks like Daimler Truck Holding AG ( ETR:DTG ) is about to go ex-dividend in the next 4 days. The ex-dividend date...

adidas AG ( ETR:ADS ) just released its latest first-quarter results and things are looking bullish. Results were good...

If you are wondering whether Deutsche Lufthansa’s €7.33 share price offers value or risk at today’s levels, key clues sit in how the market is currently weighing its fundamentals. The stock has returned 1.1% over the last 7 days, while the 30 day performance is a 2.3% decline and the year to date move is a 14.6% decline, set against an 18.9% gain over the past year and a 12.6% decline over 3 years. Investors have been reacting to ongoing sector wide themes such as capacity planning, cost...

Merck KGaA (XTRA:MRK) announced a collaboration with Remepy to develop Hybrid Drugs that pair pharmaceuticals with app-based digital therapeutics for rare and difficult-to-treat cancers. The company also introduced its first bio-based solvent portfolio for high-performance liquid chromatography, aimed at supporting more sustainable laboratory operations. For you as an investor, these moves highlight how Merck KGaA is leaning into two active themes in healthcare: digital therapeutics and...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see BASF SE...

PUMA (XTRA:PUM) has just posted its Q1 2026 scorecard, and investors are coming off a volatile 2025 where quarterly revenue moved from €2.08b in Q1 to €1.56b in Q4 while EPS swung from a small profit of essentially €0.00 in Q1 to a loss of €2.28 per share in Q4. Over the same stretch, net income shifted from a €0.5m profit in Q1 2025 to a €336.3m loss by Q4 as revenue stepped down from €2.31b in Q3 2024 to €1.56b in Q4 2025, which puts the spotlight firmly on how much of each euro of sales is...

If you are wondering whether Allianz is fairly priced or has more room to run, an effective starting point is to look closely at what the current share price implies about its value. The stock recently closed at €389.00, with returns of 8.3% over 30 days, 11.4% over 1 year and 123.1% over 5 years. These figures can influence how much risk and upside investors feel is still on the table. Recent coverage around Allianz has focused on its position as a large European insurer, its capital...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see SAP SE...

Readers hoping to buy Deutsche Post AG ( ETR:DHL ) for its dividend will need to make their move shortly, as the stock...

Mercedes-Benz Group is selling its European vehicle leasing subsidiary Athlon to BNP Paribas as part of a shift away from capital intensive financial services. The group is also challenging the UK car finance redress scheme, which could lead to significant compensation claims for historic commission arrangements. These moves highlight changing regulatory pressure around auto finance and a sharper focus on core automotive activities such as electrification and software. For investors...

Deutsche Bank (XTRA:DBK) has opened Q1 2026 earnings season with context set by Q4 2025 figures of €6.7b in revenue, basic EPS of €0.21 and net income of €416m, alongside a trailing twelve month EPS of €2.99 on revenue of €29.7b and net income of €5.8b. Over the past few quarters, revenue has ranged from €7.0b to €7.8b, while quarterly basic EPS moved between €0.21 and €1.00 and net income between €416m and €1.97b. This gives investors a clearer view of how profitability is tracking into the...

As geopolitical tensions and economic uncertainties weigh on European markets, the pan-European STOXX Europe 600 Index has recently seen a decline, with defensive sectors like utilities and telecoms showing resilience. In this environment of heightened risk, identifying undervalued stocks can offer potential opportunities for investors seeking value amid broader market volatility.

Nagarro (XTRA:NA9) has put fresh numbers on the table for FY 2025, with Q3 revenue of €254.6 million and basic EPS of €1.69, while trailing 12 month revenue stands at about €1.0 billion and EPS at €3.76. Over recent quarters, revenue has moved from €244.2 million in Q2 2024 to €252.0 million in Q2 2025, and from €246.7 million in Q4 2024 to €254.6 million in Q3 2025. EPS shifted from €0.90 and €0.59 in those 2024 quarters to €0.65 and €1.69 in the latest 2025 prints. For you as an investor,...

Wondering whether Dr. Ing. h.c. F. Porsche is attractively priced today or just looks cheap on the surface? This article walks through the numbers so you can judge how the current share price lines up with its underlying value. The stock last closed at €40.53, with returns of 6.6% over the past month but a 14.9% decline year to date and a 3.2% decline over the past year, which may have shifted how the market views its risk and reward trade off. Recent headlines around Dr. Ing. h.c. F...

Recent interest in innoscripta (XTRA:1INN) has been sparked by two corporate moves: the relocation of its registered seat to Tutzing and a fresh push into the French R&D tax incentive market via Toulouse. See our latest analysis for innoscripta. These corporate moves come after a mixed stretch for the stock, with a 30 day share price return of 9.65% offset by a 21.43% decline year to date. This suggests that recent momentum is picking up from a weaker few months. If you are curious about what...

At its Annual General Meeting on April 23, 2026, E.ON SE shareholders approved a €0.57 per share dividend for fiscal 2025 and elected Helene von Roeder and Dr. Dominik von Achten to the Supervisory Board. The addition of two senior executives from large German industrial groups may broaden E.ON’s oversight expertise as it manages capital-intensive grid investments and regulatory complexity. With the newly approved €0.57 dividend and fresh Supervisory Board expertise, we’ll now examine how...